EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
FRA:ESF0 - Deutsche Boerse Ag - FR0014000MR3 - Common Stock - Currency: EUR
ESF0 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 15 industry peers in the Life Sciences Tools & Services industry. ESF0 has only an average score on both its financial health and profitability. ESF0 has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ESF0 was profitable.
In the past year ESF0 had a positive cash flow from operations.
ESF0 had positive earnings in each of the past 5 years.
Each year in the past 5 years ESF0 had a positive operating cash flow.
1.2 Ratios
ESF0 has a Return On Assets (3.24%) which is comparable to the rest of the industry.
The Return On Equity of ESF0 (6.61%) is comparable to the rest of the industry.
ESF0 has a better Return On Invested Capital (9.18%) than 76.47% of its industry peers.
ESF0 had an Average Return On Invested Capital over the past 3 years of 8.70%. This is in line with the industry average of 6.82%.
The 3 year average ROIC (8.70%) for ESF0 is below the current ROIC(9.18%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.24% | ||
| ROE | 6.61% | ||
| ROIC | 9.18% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
The Profit Margin of ESF0 (5.08%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ESF0 has grown nicely.
The Operating Margin of ESF0 (14.97%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ESF0 has grown nicely.
ESF0 has a worse Gross Margin (22.33%) than 82.35% of its industry peers.
ESF0's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.97% | ||
| PM (TTM) | 5.08% | ||
| GM | 22.33% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
Compared to 1 year ago, ESF0 has less shares outstanding
ESF0 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ESF0 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.62 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.62, ESF0 perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
ESF0 has a debt to FCF ratio of 4.57. This is a neutral value as ESF0 would need 4.57 years to pay back of all of its debts.
With a Debt to FCF ratio value of 4.57, ESF0 perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that ESF0 is somewhat dependend on debt financing.
The Debt to Equity ratio of ESF0 (0.59) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 4.57 | ||
| Altman-Z | 2.62 |
ROIC/WACC1.36
WACC6.73%
2.3 Liquidity
ESF0 has a Current Ratio of 1.16. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0 has a worse Current ratio (1.16) than 82.35% of its industry peers.
ESF0 has a Quick Ratio of 1.09. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0's Quick ratio of 1.09 is in line compared to the rest of the industry. ESF0 outperforms 41.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.63%, which is quite impressive.
ESF0 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.34% yearly.
The Revenue has been growing slightly by 6.70% in the past year.
ESF0 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.78% yearly.
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%16.67%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
3.2 Future
Based on estimates for the next years, ESF0 will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.54% on average per year.
The Revenue is expected to grow by 7.76% on average over the next years.
EPS Next Y14.09%
EPS Next 2Y14.24%
EPS Next 3Y14.39%
EPS Next 5Y14.54%
Revenue Next Year7.56%
Revenue Next 2Y7.24%
Revenue Next 3Y7.28%
Revenue Next 5Y7.76%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ESF0 is valuated quite expensively with a Price/Earnings ratio of 28.63.
Compared to the rest of the industry, the Price/Earnings ratio of ESF0 is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.35, ESF0 is valued at the same level.
Based on the Price/Forward Earnings ratio of 14.63, the valuation of ESF0 can be described as correct.
Based on the Price/Forward Earnings ratio, ESF0 is valued cheaper than 82.35% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ESF0 to the average of the S&P500 Index (22.10), we can say ESF0 is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.63 | ||
| Fwd PE | 14.63 |
4.2 Price Multiples
ESF0's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ESF0 is cheaper than 88.24% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ESF0 is valued cheaper than 94.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.58 | ||
| EV/EBITDA | 7.47 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ESF0 does not grow enough to justify the current Price/Earnings ratio.
ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ESF0's earnings are expected to grow with 14.39% in the coming years.
PEG (NY)2.03
PEG (5Y)1.56
EPS Next 2Y14.24%
EPS Next 3Y14.39%
5. Dividend
5.1 Amount
ESF0 has a Yearly Dividend Yield of 1.16%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.79, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 88.24% of the companies listed in the same industry.
With a Dividend Yield of 1.16, ESF0 pays less dividend than the S&P500 average, which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
5.2 History
On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
27.77% of the earnings are spent on dividend by ESF0. This is a low number and sustainable payout ratio.
ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.77%
EPS Next 2Y14.24%
EPS Next 3Y14.39%
FRA:ESF0 (3/7/2025, 7:00:00 PM)
51.54
+0.66 (+1.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners33.4%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap9.95B
Analysts67
Price Target59.84 (16.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP27.77%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.39%
PT rev (3m)-0.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.12%
EPS NY rev (3m)0.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.63 | ||
| Fwd PE | 14.63 | ||
| P/S | 1.43 | ||
| P/FCF | 12.58 | ||
| P/OCF | 7.54 | ||
| P/B | 1.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.47 |
EPS(TTM)1.8
EY3.49%
EPS(NY)3.52
Fwd EY6.84%
FCF(TTM)4.1
FCFY7.95%
OCF(TTM)6.83
OCFY13.26%
SpS36.02
BVpS27.67
TBVpS-1.5
PEG (NY)2.03
PEG (5Y)1.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.24% | ||
| ROE | 6.61% | ||
| ROCE | 11.86% | ||
| ROIC | 9.18% | ||
| ROICexc | 9.87% | ||
| ROICexgc | 31.79% | ||
| OM | 14.97% | ||
| PM (TTM) | 5.08% | ||
| GM | 22.33% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexcg growth 3Y-18.17%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score8
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 4.57 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 76.4% | ||
| Cap/Sales | 7.6% | ||
| Interest Coverage | 9.11 | ||
| Cash Conversion | 76.13% | ||
| Profit Quality | 224% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 2.62 |
F-Score8
WACC6.73%
ROIC/WACC1.36
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%16.67%
EPS Next Y14.09%
EPS Next 2Y14.24%
EPS Next 3Y14.39%
EPS Next 5Y14.54%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
Revenue Next Year7.56%
Revenue Next 2Y7.24%
Revenue Next 3Y7.28%
Revenue Next 5Y7.76%
EBIT growth 1Y23.67%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year90.65%
EBIT Next 3Y34.15%
EBIT Next 5Y26.93%
FCF growth 1Y68.95%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y29.56%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%